Clinical trial
Randomized Phase IV Trial of Metronidazole Single Dose Versus 7 Day Dose for Treatment of Trichomonas Vaginalis Among HIV-infected Women
NCT01018095 is registered in ClinicalTrials.gov with Tulane University Health Sciences Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Phase IV Trial of Metronidazole Single Dose Versus 7 Day Dose for Treatment of Trichomonas Vaginalis Among HIV-infected Women
- Lead sponsor
- Tulane University Health Sciences Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- August 31, 2009
- Enrollment
- 270 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.